These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20853093)

  • 1. [Orthopoxviruses: infections in humans. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):957-72. PubMed ID: 20853093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human cytomegalovirus (HCMV). Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):973-83. PubMed ID: 20853094
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parvovirus B19. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):944-56. PubMed ID: 20853092
    [No Abstract]   [Full Text] [Related]  

  • 4. Current and emerging infectious risks of blood transfusions.
    Busch MP; Kleinman SH; Nemo GJ
    JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733
    [No Abstract]   [Full Text] [Related]  

  • 5. [XMRV is not pathogenic in human and has no significance for the safety of blood and blood products].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):1057-60. PubMed ID: 22842897
    [No Abstract]   [Full Text] [Related]  

  • 6. Reflections on the emergence of chikungunya virus in the United States: time to revisit a successful paradigm for the safety of blood-derived therapies.
    Farrugia A; Kreil TR
    Transfusion; 2015 Jan; 55(1):224-6. PubMed ID: 25582241
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing emerging infectious threats to blood safety for the blood disorders community.
    Trimble SR; Parker CS; Grant AM; Soucie JM; Reyes N
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S468-74. PubMed ID: 20331945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging viral infections‑-a potential threat for blood supply in the 21st century.
    de Mendoza C; Altisent C; Aznar JA; Batlle J; Soriano V
    AIDS Rev; 2012; 14(4):279-89. PubMed ID: 23258302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Babesia: an emerging infectious threat in transfusion medicine.
    Lobo CA; Cursino-Santos JR; Alhassan A; Rodrigues M
    PLoS Pathog; 2013; 9(7):e1003387. PubMed ID: 23853577
    [No Abstract]   [Full Text] [Related]  

  • 10. [New viral risks in blood transfusion by 2016].
    Pozzetto B; Garraud O
    Transfus Clin Biol; 2016 Feb; 23(1):20-7. PubMed ID: 26781857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging infectious disease issues in blood safety.
    Chamberland ME; Alter HJ; Busch MP; Nemo G; Ricketts M
    Emerg Infect Dis; 2001; 7(3 Suppl):552-3. PubMed ID: 11485669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism.
    Schmidt M; Roth WK; Meyer H; Seifried E; Hourfar MK
    Transfusion; 2005 Mar; 45(3):399-403. PubMed ID: 15752158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral metagenomics and blood safety.
    Sauvage V; Eloit M
    Transfus Clin Biol; 2016 Feb; 23(1):28-38. PubMed ID: 26778104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood transfusion and infectious diseases].
    Hamaguchi I
    Rinsho Byori; 2013 May; 61(5):414-7. PubMed ID: 23947180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.
    Gallagher LM; Ganz PR; Yang H; Kessler DA; O'Brien SF; Custer BS; Busch MP; Dodd RY; Stramer SL; Walderhaug MO; Forshee RA; Williams AE; Epstein JS; Anderson SA
    Transfusion; 2013 Feb; 53(2):455-63. PubMed ID: 22845334
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunobiology--the neglected side of transfusion].
    Flesland O; Solheim BG
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2493. PubMed ID: 11070981
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening for Orthopoxviruses by electron microscopy].
    Spehner D
    Med Mal Infect; 2004 Jun; 34 Suppl 1():S40-2. PubMed ID: 15676244
    [No Abstract]   [Full Text] [Related]  

  • 18. Alaskapox virus, an emerging Orthopoxvirus in the Arctic region.
    Swallow MA; Virgen CA
    Int J Dermatol; 2024 Jun; 63(6):e115-e116. PubMed ID: 38610072
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basic problems of contemporary blood donation and blood therapy].
    Sabliński J
    Acta Haematol Pol; 1995; 26(2 Suppl 1):79-85. PubMed ID: 7653238
    [No Abstract]   [Full Text] [Related]  

  • 20. The potential threat to blood transfusion safety of emerging infectious disease agents.
    Stramer SL
    Clin Adv Hematol Oncol; 2015 Jul; 13(7):420-2. PubMed ID: 26353036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.